ARIAD PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ARIAD PHARMACEUTICALS INC, 10-Q, 2000-11-09
Next: SIMULA INC, 8-A12B, 2000-11-09



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           7,600
<SECURITIES>                                    30,567
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                      1,582
<CURRENT-ASSETS>                                39,748
<PP&E>                                          17,166
<DEPRECIATION>                                (14,571)
<TOTAL-ASSETS>                                  47,246
<CURRENT-LIABILITIES>                            4,136
<BONDS>                                          1,000
                                0
                                          0
<COMMON>                                            27
<OTHER-SE>                                      42,083
<TOTAL-LIABILITY-AND-EQUITY>                    47,246
<SALES>                                              0
<TOTAL-REVENUES>                                 1,550
<CGS>                                                0
<TOTAL-COSTS>                                    9,028
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 173
<INCOME-PRETAX>                                (9,999)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (9,999)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,999)
<EPS-BASIC>                                     (0.40)
<EPS-DILUTED>                                   (0.40)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission